At risk of CHD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal hsCRP level (<2 mg/L) performed poorly as a negative risk marker, providing minimal post-test risk change for both CHD and CVD events, regardless of the cutpoint chosen.

Effect: null; DLR >0.80 for both CHD and CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD

A normal ankle-brachial index (0.9-1.3) performed poorly as a negative risk marker, providing minimal post-test risk change, despite being the most prevalent negative result (93% of participants).

Effect: null; DLR >0.80 for CVD